UroStream

15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…

15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…

“Fewer Cores Without Losing Accuracy” — A New Strategy of MRI-Targeted Biopsy Plus Ipsilateral Systematic Biopsy of the Index Lesion in Prostate Cancer Editor’s Note: Prostate cancer is one of…

Editor’s Note: Advanced urothelial carcinoma is a highly aggressive malignancy associated with poor prognosis, posing a serious threat to patient survival and quality of life. In recent years, continuous breakthroughs…

Editor’s Note The incidence of upper tract urothelial carcinoma (UTUC) in China is significantly higher than in Western countries. Although radical nephroureterectomy remains the gold standard for treatment, a substantial…

Editor’s Note: From November 10–16, 2025, the 9th West China Urologic Oncology Tianfu Academic Conference and the 11th Academic Annual Meeting on Urologic and Male Genitourinary Tumors of the Sichuan…

Editor’s note: Upper tract urothelial carcinoma (UTUC) accounts for about 17.9% of all urothelial carcinomas (UC) in China. For high-risk UTUC, radical nephroureterectomy (RNU) is the standard surgical procedure, but…

Editor’s note: The incidence of genitourinary cancers in China has continued to rise, with prostate, bladder, and kidney cancers ranking among the most common malignancies. Among them, eosinophilic renal tumors…

From November 6–9, 2025, the China Congress of Holistic Integrative Oncology (CCHIO 2025) took place in Kunming. The conference was hosted by the China Anti-Cancer Association (CACA) and the Tengchong Scientist Forum Organizing Committee, co-organized by the World Association of Integrative Oncology (WAIO) and the China Academy of Integrative Medicine, and jointly undertaken by Yunnan Cancer Hospital, Kunming Medical University, and the Yunnan Anti-Cancer Association. As urologic cancers remain among the world’s most common malignancies, advances in this field garnered significant attention at CCHIO 2025. Oncology Frontier – Urology Frontier invited Prof. Gang Zhu, Chair of the CACA Committee on Integrative Rehabilitation for Genitourinary Tumors and Professor at Beijing United Family Hospital and Clinics, to discuss the clinical value of holographic imaging in robotic surgery, its integration with systemic therapies, and his perspectives on training young surgeons.

On November 14, a research team led by Prof. Kan Gong and Associate Chief Physician Yi Liu from the Department of Urology, Peking University First Hospital and the Institute of Urology, Peking University, published a major advancement in precision prostate biopsy in eClinicalMedicine, a sub-journal of The Lancet.